Recombinant Human TSLP, Peprotech, Inc.Supplier: Peprotech
300-62-1MG 300-62-250UG 300-62-10UG 300-62-2UG 300-62-500UG 300-62-100UG
10774-084EA 9759.89 CAD10774-084 10774-080 10774-076 10774-074 10774-082 10774-078
Recombinant Human TSLP, Peprotech, Inc.
Proteins and Peptides
TSLP is a hemopoietic protein that is expressed in the heart, liver and prostate. TSLP overlaps biological activities with IL-7, and binds with the heterodimeric receptor complex consisting of the IL-7R α-chain (IL-7Rα) and the TSLP-specific chain (TSLPR). Like IL-7, TSLP induces phosphorylation of STAT3 and STAT5, but uses kinases other than the JAKs for activation. TSLP prohibits apoptosis and stimulates growth of the human acute myeloid leukemia (AML)-derived cell line MUTZ3. It induces the release of T cell-attracting chemokines TARC and MDC from monocytes, and activates CD11c (+) dendritic cells (DCs). TSLP-activated DCs have been shown to prime naïve T cells to produce the proallergic cytokines (IL-4, IL-5, IL-13, TNF-α) while down-regulating IL-10 and IFN-γ, suggesting a role in initiating allergic inflammation. Recombinant Human TSLP is a 15.0 kDa protein consisting of 132 amino acid residues.
Ordering information: For research use only. Not for use in diagnostic or therapeutic procedures.